Aspen Pharmacare Holdings Cash Flow Statement

Financials in millions ZAR. Fiscal year is July - June.

Millions ZAR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-1,999	-1,083	4,404	5,228	6,488	4,806
Depreciation & Amortization	1,799	1,753	1,628	1,455	1,373	1,265
Other Amortization	336	336	345	333	340	372
Loss (Gain) From Sale of Assets	22	22	34	1	-1,212	-165
Asset Writedown & Restructuring Costs	4,806	4,806	1,667	1,986	1,573	1,115
Stock-Based Compensation	109	109	117	135	58	67
Provision & Write-off of Bad Debts	272	272	11	-	-	-
Other Operating Activities	1,458	547	-1,739	-260	-594	-1,299
Change in Accounts Receivable	-773	-773	-104	327	-1,355	348
Change in Inventory	-704	-704	200	-2,701	-2,168	-280
Change in Accounts Payable	-126	-126	-338	-984	871	580
Operating Cash Flow	6,931	5,159	6,225	5,520	5,374	6,825
Operating Cash Flow Growth	24.39%	-17.12%	12.77%	2.72%	-21.26%	-17.37%
Capital Expenditures	-2,507	-2,576	-3,117	-2,230	-1,963	-2,045
Sale of Property, Plant & Equipment	43	34	13	5	1,830	38
Cash Acquisitions	-159	-229	-4,350	-626	-2,188	-632
Divestitures	6	6	945	279	434	-
Sale (Purchase) of Intangibles	-1,471	-2,451	-2,416	-947	-409	-1,011
Investment in Securities	-	-	52	38	-	-
Other Investing Activities	-	-	-595	60	135	13,413
Investing Cash Flow	-4,088	-5,216	-9,468	-3,421	-2,161	9,763
Long-Term Debt Issued	-	9,880	13,988	7,939	14,208	14,668
Long-Term Debt Repaid	-	-8,373	-8,784	-6,768	-15,831	-30,266
Net Debt Issued (Repaid)	-1,552	1,507	5,204	1,171	-1,623	-15,598
Repurchase of Common Stock	-6	-68	-56	-136	-1,857	-50
Common Dividends Paid	-941	-1,601	-1,525	-1,455	-1,196	-
Financing Cash Flow	-2,499	-162	3,623	-420	-4,676	-15,648
Foreign Exchange Rate Adjustments	-506	-592	-653	843	479	-602
Net Cash Flow	-162	-811	-273	2,522	-984	338
Free Cash Flow	4,424	2,583	3,108	3,290	3,411	4,780
Free Cash Flow Growth	60.87%	-16.89%	-5.53%	-3.55%	-28.64%	-23.16%
Free Cash Flow Margin	10.39%	5.96%	6.95%	8.08%	8.83%	12.66%
Free Cash Flow Per Share	9.96	5.82	7.00	7.41	7.53	10.47
Cash Interest Paid	1,535	1,649	2,227	1,324	765	1,205
Cash Income Tax Paid	1,039	1,757	2,149	1,614	1,691	1,630
Levered Free Cash Flow	-17,676	-177.63	260.5	1,776	-261.63	8,820
Unlevered Free Cash Flow	-16,529	894.25	1,685	2,628	256.5	9,603
Change in Working Capital	373	-1,603	-242	-3,358	-2,652	648

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.